QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-maintains-outperform-on-opko-health-raises-price-target-to-225

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and raises the price target...

 opko-health-q2-2024-gaap-eps-001-beats-009-estimate-sales-182200m-miss-185190m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.09) by...

 opko-health-stock-is-climbing-whats-going-on

Opko Health shares are trading higher Thursday after the company announced a $100 million share repurchase program. Here's ...

 piper-sandler-maintains-overweight-on-opko-health-lowers-price-target-to-3

Piper Sandler analyst Edward Tenthoff maintains OPKO Health (NASDAQ:OPK) with a Overweight and lowers the price target from ...

 why-opko-health-shares-are-up-after-hours

Opko Health shares are trading higher after-hours Wednesday. The company announced it has entered into a $250 million non-dilut...

Core News & Articles

New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additional E-Commerce Platform...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 opko-health-q1-2024-gaap-eps-012-misses-010-estimate-sales-173700m-miss-182990m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) ...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 barrington-research-maintains-outperform-on-opko-health-maintains-15-price-target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $1.5 price ta...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION